VIRGILIO, Eleonora
 Distribuzione geografica
Continente #
EU - Europa 353
NA - Nord America 290
AS - Asia 89
SA - Sud America 1
Totale 733
Nazione #
US - Stati Uniti d'America 288
IE - Irlanda 160
SE - Svezia 56
IT - Italia 52
DE - Germania 48
HK - Hong Kong 36
SG - Singapore 23
UA - Ucraina 14
CN - Cina 8
CZ - Repubblica Ceca 6
IR - Iran 6
FI - Finlandia 4
IN - India 4
VN - Vietnam 4
FR - Francia 3
KR - Corea 3
NL - Olanda 3
PK - Pakistan 3
BE - Belgio 2
CA - Canada 2
GB - Regno Unito 2
RU - Federazione Russa 2
TR - Turchia 2
BR - Brasile 1
GR - Grecia 1
Totale 733
Città #
Dublin 158
Chandler 40
Hong Kong 36
Jacksonville 25
Boardman 18
Singapore 16
Bremen 15
Lawrence 15
Princeton 15
Ann Arbor 12
Wilmington 8
Dearborn 7
Georgetown 7
Monmouth Junction 7
San Mateo 7
Brno 6
Ashburn 5
Grafing 5
Milan 5
Munich 5
Mülheim 5
Novara 5
Dong Ket 4
Helsinki 4
Amsterdam 3
Bari 3
Beijing 3
Gangnam-gu 3
Leawood 3
Piemonte 3
Sacramento 3
Strasbourg 3
Andover 2
Brussels 2
Cilavegna 2
Fairfield 2
Izmir 2
Menlo Park 2
New York 2
Norwalk 2
Nuremberg 2
Torino 2
Turin 2
Woodbridge 2
Yekaterinburg 2
Zanjan 2
Alessandria 1
Ardabil 1
Belo Horizonte 1
Berlin 1
Borgomasino 1
Brindisi 1
Bulandshahr 1
Caltignaga 1
Cassano Magnago 1
Cologne 1
Hefei 1
Houston 1
Ivrea 1
Jinan 1
Mcallen 1
Nanchang 1
Nanjing 1
Nichelino 1
Nocera Inferiore 1
Ottawa 1
Philadelphia 1
Portland 1
Redwood City 1
Rome 1
San Giorgio Su Legnano 1
San Marco dei Cavoti 1
Seattle 1
Shanghai 1
Verolengo 1
Vigevano 1
Winnipeg 1
Totale 513
Nome #
Kappa free light chains could predict early disease course in multiple sclerosis 80
K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up 53
The Yin-Yang of osteopontin in nervous system diseases: Damage versus repair 52
MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis 48
Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population 46
Intrathecal kappa free light chains as markers for multiple sclerosis 43
Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis 40
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 35
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 34
Susac Syndrome: an uncommon cause of impaired vision 34
Cannabinoids in multiple sclerosis: A neurophysiological analysis 33
Paraneoplastic neuromyelitis optica spectrum disorders: a case series 32
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 29
Efficacy of Cannabinoids on Spasticity and Chronic Pain in a Patient with Co-occurrence of Multiple Sclerosis and Neurofibromatosis Type 1 29
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis 28
Early Successful Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Verbal Memory Impairment in an Adjustment Disorder: A Case Report in a Newly-Diagnosed Multiple Sclerosis Patient 23
Serum vitamin d as a marker of impaired information processing speed and early disability in multiple sclerosis patients 21
Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis 20
Exploring serum and CSF Calcitonin Gene Related Peptide levels: A promising biomarker in multiple sclerosis? 17
Safety of COVID-19 Vaccines: Spotlight on Neurological Complications 17
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 14
Prognostic Role of Visual Evoked Potentials in Non-Neuritic Eyes at Multiple Sclerosis Diagnosis 12
COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature 8
Fluid Biomarkers of Disability and Cognitive Impairment in Multiple Sclerosis Patients 6
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 6
CGRP beyond migraine: exploring its serum and CSF levels in multiple sclerosis. 6
Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients 2
Totale 768
Categoria #
all - tutte 5.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 0 3
2019/202037 0 0 4 0 5 5 7 3 5 2 5 1
2020/202160 3 2 4 0 6 10 8 4 8 0 10 5
2021/2022105 10 0 10 3 3 1 9 7 13 15 9 25
2022/2023340 15 15 24 3 35 27 19 7 158 6 20 11
2023/2024214 18 11 19 5 20 9 41 7 12 4 19 49
Totale 768